BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:As the allogeneic cell therapy space continues to mature with over 150+ clinical trials currently underway\, and landmark milestones ac hieved with the first FDA approvals for allogeneic cell products - all ey es are turning to the backbones of these cell therapies - the cell donors . The field is awakening to the challenging reality of the increased dema nd for donor material to meet the required dosing needs for later stage c linical trials and licensed products.\n\nEnter the timely arrival of the inaugural Donor Selection and Cell Source Summit\, the pioneering forum f or cell therapy leaders within process development\, supply chain\, procu rement\, R and D and analytics\, placing a spotlight focus on cell source starting material for the first time.\n\nWith experts showcasing in-dept h case studies of novel technology platforms and cell sources being utili zed to increase yield\, and new donor characteristic screening strategies to select for 'gold-standard' donors to achieve optimal clinical results for patients.\n\nGet caught up to speed on this dynamic space with exper tise shared from the likes of Allogene\, Caribou Bio\, Poseida Therapeuti cs\, and many others as the titans of industry unite to help you advance your knowledge on donor selection\, management and sustainability to ensu re a consistent and reliable supply of cell source material required for clinical trials and beyond.\n\nFind out more in the event guide - \;h ttps://ter.li/t8oe61\n\nRegister to attend - \;https://ter.li/kss0d6\ n\nURLs:Tickets: \;https://go.evvnt.com/1900606-2?pid=185Brochure:&nb sp\;https://go.evvnt.com/1900606-3?pid=185\n\nPrices:Full Conference Acce ss - Drug Developer: USD 4297.00\,Conference + 1 Workshop - Drug Develope r: USD 3648.00\,Conference Only - Drug Developer: USD 2999.00\,Full Confe rence Access - Academic and Research Institute: USD 3697.00\,Conference + 1 Workshop - Academic and Research Institute: USD 3148.00\,Conference On ly - Academic and Research Institute: USD 2599.00\,Full Conference Access - Service Provider: USD 5297.00\,Conference + 1 Workshop - Service Provi der: USD 4548.00\,Conference Only - Service Provider: USD 3799.00\n\nSpea kers: \;Aaron Goldman - Instructor in Medicine | Director of Drug Res istance - Brigham and Women's Hospital\, Allen Feng - Founder | CSO - Heb eCell\, Amanda Conerty - Exec. Director Process\, Analytical Development and Manufacturing - Artiva Biotherapeutics\, Colleen Delaney - Founder | CSO | EVP of Research and Development - Deverra Therapeutics\, Evren Alic i - Associate Professor | Co-Director - NextGenNK Competence Center Karol inska Institute\, Greg Whitehead - Senior Vice President | Quality - Edit as Medicine\, James Liu - Research Associate II - ImmuneBridge\, Jennifer Collins - Vice President | Supply Chain - Poseida Therapeutics\, Jesse C otari - CSO and Co-Founder - ImmuneBridge\, Juliana Vergara - Principal S cientist | Process Development - Senti Biosciences\, Kevin King - Senior Director of Donor Center Strategy and Growth - BioIVT\, Kevin Liao - Asso ciate Director | Supply Chain - Caribou Bio\, Lavakumar Karyampudi - Dire ctor | Cell Therapy and Facility - Moffitt Cancer Center\, Martin Maiers - Vice President | Research - Be The Match BioTherapies\, Nina Horowitz - Head of Research | NK Therapeutics - ImmuneBridge\, Patrick Hanley - Chi ef and Director | Cellular Therapy Program - National Children's Hospital \, Stacey Cranert - Director | Immunoncology - Poseida Therapeutics\, Wil l Bobbitt - Senior Research Associate I - Senti Biosciences\, Ying He - D irector - Allogene\n\nTime: \;9:00 am to 3:30 pm\n DTEND:20231130T153000 DTSTAMP:20260512T231937Z DTSTART:20231128T090000 LOCATION:The Clift Royal Sonesta San Francisco\, 495\, Geary Street\, San Francisco\, California\, 94102\, SEQUENCE:0 SUMMARY:As the allogeneic cell therapy space continues to mature with over 150+ clinical trials currently underway\, and landmark milestones achiev ed with t... UID:2510ccfd-29f5-48ae-a8c9-a8c0803b8991 END:VEVENT END:VCALENDAR